HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease.
Clin Gastroenterol Hepatol
; 20(4): e890-e894, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-33895359
ABSTRACT
Physicians use portal pressure measurements in clinical practice and research but the methods are invasive, can cause complications, and are resource intensive.1-3 Herein we describe preliminary findings of the minimally invasive HepQuant-SHUNT test in the diagnosis of portal hypertension in precirrhotic and compensated cirrhotic patients.
Full text:
1
Database:
MEDLINE
Main subject:
Hypertension, Portal
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Year:
2022
Type:
Article